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crystal microbalance biosensor for the real time
analysis of carcinoembryonic antigen†
P. J. Jandas, ab Jingting Luo,*a Aojie Quan,a Chong Li,a Chen Fu*a and Y. Q. Fu c
A label-free quartz crystal microbalance (QCM) biosensor was developed for the selective and real-time
estimation of carcinoembryonic antigen (CEA) through the present study. Graphene oxide-Au
nanoparticles (GO-AuNPs) was in situ synthesised on the surface of the QCM electrode and the antibody
of CEA (monoclonal anti-CEA from mouse) was covalently immobilized on this layer as the bioreceptor
for CEA. Mercaptoacetic acid–EDC–NHS reaction mechanism was used for anti-CEA immobilization.
The eﬀect of oxygen plasma treatment of the QCM electrode surface before bioreceptor preparation on
the performance of the biosensor was tested and was found promising. CEA solutions with various
concentrations were analysed using the bioreceptors to estimate the sensitivity and detection limit of the
biosensor. The biosensors selectively recognized and captured CEA biomolecules with a detection limit
of 0.06 and 0.09 ng mL1 of CEA for oxygen plasma-treated (E2) and untreated (E1) bioreceptors,
respectively. The sensitivity was estimated at 102 and 79 Hz, respectively, for E2 and E1. Clinical serum
samples were analysed and the results were found in good agreement with the ELISA analysis. Long term
stability was also found to be excellent. Langmuir adsorption isotherm was also conducted using the
experimental results.1. Introduction
Abnormally high level of carcinoembryonic antigen (CEA) in the
human body is oen attributed to the presence of cancer in any
of the organs including colon, breast, lungs, gastrointestinal
tract, and ovary.1 The average level of CEA in a healthy human
body is 5 mg L1. Any value of CEA higher than 20 mg L1 is
considered as an alarm signal for the presence of tumour cells
in the body. The rapid, accurate, and periodical detection of
CEA concentration provides helpful information about the
stage, progression, and recurrence of cancer.2 A majority of
present methods use antigen (analyte) and antibody (the
receptor system) based detection strategy with detectors based
on colorimetry, uorescence, chemiluminescence, electro-
chemistry, surface-enhanced Raman scattering, etc.3,4
However, the sensitivity of many of these devices is a critical
issue. Popular methods such as enzyme-linked immunosorbentFilms and Applications, College of Physics
Shenzhen, PR China. E-mail: luojt@szu.
nd Systems of Ministry of Education and
ronic Engineering, Shenzhen University,
Northumbria University, Newcastle upon
tion (ESI) available. See DOI:assay (ELISA), radioimmunoassay, and Raman readouts have
potential problems such as low sensitivity, long detection time,
safety issues, and reproducibility of the results. Electrochemical
methods have been studied extensively but the methods
demand complicated labelling process to ensure high sensi-
tivity.5,6 This makes the method labour-intensive and some-
times labelling may also hinder the activity of the biomolecules.
In this perspective, label-free, highly sensitive, safe, and real-
time analysis of tumour markers is still an active challenge
for researchers.
Piezoelectric biosensors such as surface acoustic wave (SAW)
sensors and quartz crystal microbalance (QCM) sensors are
popular today.7 The QCM sensor is a priority tool for biomo-
lecular analysis because of its unique advantages such as high
sensitivity, low response time, easy operation, portable device,
cost-eﬀectiveness, and label-free and real-time detection
ability.8 The QCM electrode consists of a quartz electrode
sandwiched by metal (Au, Al, Ti, etc.) layers for electrical
contact. Any mass deposition on the electrode tends to change
the frequency response of the crystal. This can be detected by an
analyser system with high accuracy.9 The QCM based biosen-
sors are popular for the analysis of DNA molecules,10 proteins,11
cancer diagnosis, tumour marker detection,12 and diﬀerentia-
tion between cancerous and normal cells.13 Chen and Tang have
presented a QCM-based biosensor for the detection of CEA
based on a bioreceptor prepared through non-covalent inter-
actions.14 Yang et al. have described a QCM based CD44This journal is © The Royal Society of Chemistry 2020
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View Article Onlinebiosensor for the analysis of metastatic potential of breast
cancer cells.15 Recently, Uludag and Tothill reported a system-
atic approach for human serum sample analysis for tumour
markers using QCM.16 The detection of E. coli O157: H7 was
reported by Yu et al., which also suggested the eﬀectiveness of
the QCM tool for the detection of microorganisms.17 Another
recent notable investigation in QCM based biosensors was by D.
Tang.18 The study illustrated a systematic method for the
determination of tumour necrosis factor alpha using a piezo-
electric biosensor.
In the present study, a QCM based biosensor was prepared
for the detection of CEA with good selectivity, sensitivity,
stability, and reproducibility. The immobilization of anti-CEA
on the QCM electrode surface is a vital and challenging part
of the biosensor fabrication process. This is because the bio-
receptor surface needs to act like an active and selective host for
the CEA molecules from the analyte sample. This is possible
only if we can immobilize a uniform anti-CEA layer on the QCM
electrode surface. The study presents a novel method for bio-
receptor preparation using a nanomaterial cluster of GO-AuNPs.
The GO akes are proven materials for biosensing as they
provide easy transduction of signals from biochemical reactions
to electrode outputs.19,20 AuNP can act as a reaction nucleus for
the immobilization of anti-CEA by creating a covalent interac-
tions with the sulphur atom of mercaptoacetic acid. A range of
CEA concentration from 0.1 ng mL1 to 120 ng mL1 was used
for immunoassay analysis in the present study. The mass of
CEA deposited on the SAM was calculated using modied
Souerbrey's equation for liquid state analysis.
2. Experimental
2.1. Materials and instruments
All the chemicals and biological samples including cancer-
associated carcinoembryonic antigen (CEA), CEA monoclonal
antibody (anti-CEA) produced in mouse, alpha-1-fetoprotein (AFP,
Monoclonal Anti-a-Fetoprotein produced in mouse), and L-tryp-
tophan ((S)-2-amino-3-(3-indolyl)propionic acid), bovine serum
albumin (BSA, 96–99%), mercaptoacetic acid, ethyl-dimethyl-
aminopropyl carbodiimide (EDC), N-hydroxy succinimide (NHS),
sodium citrate, HAuCl4$3H2O, and all other common reagents
were purchased from Sigma Aldrich, USA. Cancer antigen 125
(CA125, Biotinylated Human CA125/MUC16 Protein, Fc, Avitag)
was purchased from Biosystem ACRO, USA. Clinical serum
samples were supplied by Second People's Hospital, Shenzhen,
China. The samples were collected from the patients who were
suspected to be aﬀected by colorectal cancer. A buﬀer solution
with pH 7.4 was prepared using K2HPO4 and KHPO4. BSA solution
with the concentration of 10 mg mL1 was prepared and used.
Both the solutions were prepared freshly for each use. The CEA
solutions of concentrations in the range of 0.1 ng mL1 to 100 ng
mL1 were prepared in PBS solution and stored in sterile condi-
tions. The CEA sample obtained was tested for activity using
ELISA method.
QCM with impedance measurement (QCM-I, MicroVacuum
Ltd, Hungary) with electrode consists of AT cut optically polished
circular quartz crystal (15 mm diameter, TiAuTi) was used for theThis journal is © The Royal Society of Chemistry 2020measurements. The basic resonant frequency of the crystal was 5
MHz and the frequency shi of the normalized 5th overtone was
used to quantify CEA during immunoassay experiments.2.2. Electrode pre-treatment and bioreceptor preparation
The QCM electrode crystal was cleaned by sonication in ethanol
for 10 minutes. The surface was degreased using piranha
solution (1 : 3, H2O2 : H2SO4) for 20 minutes, followed by
washing in deionised water (DI water) and ethanol. The surface
was then dried at 80 C in a vacuum oven under nitrogen ow.
0.05 g of GO was taken in a beaker containing 5 mL of DI water.
The mixture was heated to 80 C and 2.50 mL of 10.35 mg mL1
of sodium citrate was added, followed by addition of 1 mL 5 mg
mL1 aqueous solution of HAuCl4$3H2O. The resulting
precursor solution was sonicated for 5 minutes and added to
1 mL of the solution on the QCM electrode surface. The elec-
trode was further incubated in a vacuum oven for 30 minutes at
80 C under nitrogen atmosphere. The nanoparticle coated
electrode was cooled using an ice bath, washed with DI water,
followed by ethanol. SEM, TEM, and AFM images of the surfaces
were taken to understand the morphology. Further, thioglycolic
acid (5 mM) was introduced on the GO-AuNP surface and
allowed to react for 2 hours. The surface was washed with
ethanol, followed by DI water and dried under nitrogen ow.
2mL solutionmixture of 400mMEDC and 100mMNHS (1 : 1 v/
v) in methanol was allowed to react with the surface in the next
stage. In the next step, the surface was treated with 100 mg mL1
of capture monoclonal anti-CEA and incubated at 4 C and 50
5% relative humidity for 12 hours. The concentration of
monoclonal anti-CEA was optimized through QCM analysis
aer immobilization with various concentrations and theoret-
ical calculation of fractional coverage of electrode surface (the
results are given in the supportive data, Table S4†). The surface
was cleaned with PBS solution and dried under nitrogen ow
aer the incubation period. The electrode crystals were stored at
4 C and 50  5% under sterile conditions to avoid any
contamination. The bioreceptor surface was characterized
using scanning electron microscopy (SEM, Zeiss EVO-MA),
atomic force microscopy (Bruker NanoWizard® 4), optical/
uorescence microscopy (Ningbo Sunny Technology Co. Ltd,
CX40 Biological optical/uorescence microscope), and contact
angle study (United Test Co., Ltd, CAG100 Contact Angle
Goniometer).
Oxygen plasma treatment. The chemically cleaned Au
surface using piranha solution was treated with O2 plasma
using RGC-100 Series Digital Vacuum Gauge, Agilent Technol-
ogies. The power of oxygen plasma and time of exposure were
optimized to 120 watts and 10 minutes, respectively. Immedi-
ately aer the plasma exposure, the surface underwent bio-
receptor preparation processes as discussed in the above
section. The hypothesis behind oxygen plasma treatment is that
ionized oxygen can activate the electrode surface and provide
good adhesion with the nanomaterial cluster. The plasma
treatment may also provide better eﬀective surface area for the
bioreceptor preparation and potential reaction sites as
compared with the untreated QCM electrode surface.RSC Adv., 2020, 10, 4118–4128 | 4119
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View Article Online2.3. Biosensing using QCM
The frequency shi of each immunoassay run was recorded as
a function of response time at an interval of 5 seconds using
a data acquisition system connected to a computer with the
QCM instrument. The ow rate of the sample for the entire
experiment was optimized to 0.05 mL per minute. Newly
prepared biosensors were treated with BSA before immunoassay
runs to minimize unwanted adsorptions. Fixed volumes of CEA
solutions with variable concentrations ranging from 0.1 ng
mL1 to 120 ng mL1 were allowed to ow through the receptor
cell of the QCM instrument till a stable plateau was obtained. At
the end of each immunoassay analysis, the bioreceptor was
washed with PBS solution. The nal average values of equilib-
rium frequency shi with standard deviation are reported in
a previous study.21 Aer each immunoassay measurement,
regeneration of SAM was conducted by running a buﬀer solu-
tion of HCl (0.8 M), KCl (0.06 M), and glycine (0.06 M) for half an
hour or till getting a stable plateau. The frequency shi was
converted to the amount of CEA deposited on the bioreceptor
through calculation using modied Sauerbrey's equation for
liquid phase experiments.22–243. Results and discussion
3.1. Characterization of nanomaterial coated QCM surface
TEM images of GO and GO-AuNP are given in Fig. 1A and B. The
2D single layers of GO prepared through modied Hummer's
method are clearly detectable from the TEM images. The
separate layers of GO have an average surface dimension of 40Fig. 1 (A) TEM of graphene oxide synthesised by modiﬁed Hummer's m
TEM-EDS elemental mapping of GO-AuNP.
4120 | RSC Adv., 2020, 10, 4118–4128 60 nm. AuNP of dimension around 5–10 nm were found to be
formed on the GO layers as given in Fig. 1B. The brighter spots
on the GO layers represent the AuNP. This has been further
conrmed by using the SEM images. The SEM gures of GO-
AuNP coated QCM electrodes are given in Fig. 2A–C. Fig. 2A
represents the surface of piranha treated QCM electrode. Fig. 2B
and C represent the GO-AuNP coated surfaces of E1 and E2,
respectively. Well formed AuNP on the GO layers are visible
within the gures and number density of the particles was
found to be better on the E2 electrode than that of E1. The
oxygen plasma may enhance the energy state of the Ti coated
electrode surface and may provide better adhesion for the
nanoparticles during the in situ formation process. This may be
the reason for better particle density on the E2 electrode
surface.
AFM analysis provides additional evidence for the formation
of GO-AuNP coating on the QCM electrode, as given in Fig. 3A
and B. The AFM gures give an idea about the thickness of the
thin lm of the nanoparticles formed on the electrode surfaces.
An average of 50 nm thickness was observed for both the
methods of electrode preparations. The pillar-like structures in
the AFM images represent the coated nanoparticles on the
surface. The thickness of the nanoparticle layers suggests that
3–4 GO-AuNP layers were deposited on the electrode surface.3.2. Characterization of self-assembled monolayer (SAM)
bioreceptor
The bioreceptor preparation steps were monitored using QCM
analysis to study the deposition of nanomaterial andethod (B and C) TEM of GO-AuNP synthesised in the present study (D)
This journal is © The Royal Society of Chemistry 2020
Fig. 2 (A) Surface morphology of piranha treated QCM electrode (B) GO-AuNP synthesised on the QCM electrode E1 and (C) GO-AuNP
synthesised on the QCM electrode E2.
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View Article Onlinebiomolecular lm on the electrode surface. Fig. 4A represents
the frequency response towards the PBS run before and aer the
SAM preparation for E1 and E2 electrodes. Aer the GO-AuNP
thin lm coating, the frequency shi of E2 changed to an
average value of about 165 Hz and aer the immobilization of
anti-CEA to about 15 623 Hz. E1 responded to the PBSFig. 3 (A) E1 electrode after coating with GO-AuNP (B) E2 electrode afte
(D) E2 electrode after bioreceptor preparation.
This journal is © The Royal Society of Chemistry 2020solutions at 111 Hz and 13 567 Hz, respectively, aer the
GO-AuNP thin lm coating and anti-CEA immobilization. The
reduced frequency shi points to the successful addition of GO-
AuNP thin lm and immobilization of anti-CEA bioreceptor lm
on the surface of the QCM electrode crystal. The higher devia-
tion in the frequency in the case of E2 than for E1 is due tor coating with GO-AuNP (C) E1 electrode after bioreceptor preparation
RSC Adv., 2020, 10, 4118–4128 | 4121
Fig. 4 (A) Frequency shift of QCM after GO-AuNP coating and bio-
receptor preparation PBS ﬂow (pH – 7.4) at room temperature. (B) The
scheme of biosensing used in the present study.
Fig. 5 (A) and (B) Morphology of the bioreceptor prepared on E1 and E2
4122 | RSC Adv., 2020, 10, 4118–4128
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View Article Onlinebetter wetting of the QCM electrode surface by nanoparticles
aer oxygen plasma treatment. More number of AuNPs on the
surface ultimately provide higher number of reaction sites to
immobilize anti-CEA molecules. The high energy plasma
particles may activate the Ti atoms from the electrode surface
and can adhere with larger number of reaction nanoparticles
than that under normal conditions. This may end up in a denser
anti-CEA lm on the bioreceptor surface.
SEM images of E1 and E2 (Fig. 5A and B, respectively) display
a well-formed new layer of SAM on the electrode crystal. The
rough morphology of the nanomaterial coated electrode crystal
shows it to be covered with a thin lm of biological molecule
based SAM. The magnied gures of each surface (60k) are
given in Fig. 5C and D. Individual reactive nuclei created by the
immobilization of anti-CEA are visible in the gures. The
number of reactive nuclei on the bioreceptor surface was
observed to be higher for E2 than E1. The AFM images also
suggest the formation of a new layer of SAM on the surface of
QCM electrode, which is depicted in Fig. 3C and D, respectively,
for E1 and E2. The topographic images of E1 and E2 have many
‘ups and downs’ due to the presence of immobilized anti-CEA
molecules. The thickness of the newly formed layer is about
1000–1200 nm, which suggests the formation of a monolayer of
anti-CEA molecules on the bioreceptor surface.
Thioglycolic acid has the capability to interact with AuNPs on
the surface of the electrode crystal with stable chemical and
physical bonds. According to T. Bu¨rgi, sulphur molecules can(C) and (D) magniﬁed morphology of E1 and E2.
This journal is © The Royal Society of Chemistry 2020
Fig. 6 (A) The interactive pattern of AuNP and thioglycolic acid (B) the
chemistry behind the anti-CEA immobilization.
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View Article Onlineform coordination bonds with transition metal elements.25 The
vacant outermost orbital of Au can interact with lone pairs of
sulphur to form a stable coordination linkage between AuNP on
the electrode crystal surface and thioglycolic acid. The
maximum bond energy reported for S–Au linkage is
184 kJ mol1.25 Further, the thin layer of carboxylic acid termi-
nated thioglycolic acid can be activated through the EDC–NHS
coupling agent to form semi-stable acylamino ester intermedi-
ates, as given in Fig. 6A and B. These acylamino ester groups can
interact with the primary amine groups of anti-CEA moleculesFig. 7 (A) Contact angle of piranha cleanedQCM electrode surface (B)
contact angle of E1 surface after GO-AuNP coating (C) contact angle
of E2 surface after GO-AuNP coating (D) E1 bioreceptor after anti-CEA
immobilization (E) E2 bioreceptor after anti-CEA immobilization.
This journal is © The Royal Society of Chemistry 2020to undergo substitution reaction to form a covalently bonded
stable bioreceptors for CEA capture.
The immobilization of anti-CEA also has an eﬀect on the
hydrophilic characteristics of the electrode surface. The same
was characterized and the results are depicted in Fig. 7. The
clean Au surface had a contact angle of 82, which was reduced
to 71 and 73 aer nanomaterial coating and further reduced
to 23 and 21 aer anti-CEA immobilization, respectively, for
E1 and E2. The presence of polar hydrophilic biological mole-
cules tends to enhance the hydrophilicity of the electrode
surface aer the formation of the bioreceptor. This further
conrms the successful formation of biolm on the QCM
electrode surface through themethod used in the present study.3.3. Immunoassay run for CEA solutions
The biosensing capability and limit of detection of the newly
prepared biosensors were estimated by performing a series of
immunoassay runs with diﬀerent stock solutions of CEA
prepared in PBS at pH 7.4. The general principle of biosensing
of CEA in the present research is depicted in Fig. 4B. The
prepared biosensor was treated with BSA solution prior to
immunoassay experiments to reduce the non-specic adsorp-
tion of CEA. Multiple immunoassay runs were conducted for
each concentration of CEA stock solution and the representative
image of the immunoassay response of the biosensors are
depicted in Fig. 8A and 9A, respectively, for E1 and E2. The
corresponding average values of variation in the frequency
response for each CEA concentration from the base frequency of
the respective biosensors are given in Fig. 8B and 9B (standard
deviations (S.D.) are shown as error bars). The calibration
curves as log–log plots to determine the lower and upper limit of
detection are given in Fig. 8C and 9C. The nal value of
frequency shi was obtained aer PBS washing at the end of
each immunoassay run. The bioreceptor E2 was responded
linearly with increase in the concentration of CEA, as the
frequency response decreased from 0.1 ng mL1 CEA to 120 ng
mL1. The immunoassay experiment was conducted for 0.01 ng
mL1 CEA as well. However, the solution could not create any
considerable variation in the base frequency of the biosensor
E2. Hence, the corresponding frequency response is not given in
the gure. The biosensor E2 responded to 0.1 ng mL1 of CEA
with variation in the equilibrium frequency from the base
frequency of about 12.5 Hz. Further, the frequency shied to
the lower side consistently with increasing CEA concentration
and a maximum value of deviation at the frequency shi
13 260 Hz was recorded for 120 ng mL1. Similarly, biosensor
E1 also responded to the CEA stock solutions (Fig. 8A and C);
however, the values are comparably lower to that of E2 for each
concentration of CEA stock solutions. The E1 bioreceptor
responded to 0.1 ng mL1 stock solution with an oscillation
frequency of 8.5 and 7120 Hz for 100 ng mL1 solution. Oxygen
plasma treatment at the beginning of bioreceptor preparation
may end up providing a better eﬀective area for the bioreceptor
and better accessibility for prey CEA molecules during the
immunoassay run, thereby giving lower oscillation frequency.
As expected, the Ti atoms may get excited to an energeticallyRSC Adv., 2020, 10, 4118–4128 | 4123
Fig. 8 (A) Immunoassay response of E1 (B) average value of variation in oscillation frequency from base value of E1 (C) calibration curves of E1.
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View Article Onlinehigher state under oxygen plasma and more nanoparticles may
adhere on the surface. A higher number of AuNP can react with
thioglycolic acid, which ultimately creates more reaction sites
for CEA immobilization as compared with the untreated one.
This tends to create better eﬀective surface for the bioreceptor
E2 with more immobilized anti-CEA molecules than that for E1.
This may be the reason for higher frequency shi for E2 than for
E1 during the immunoassay analysis.
The response time of the bioreceptor was also found to be
good and comparable or better than some of the reported values
by various researchers.26–29 In the present study, the equilibrium
plateau was attained for each immunoassay run within
a minimum time period of 15–30 minutes. The limit of detec-
tion for both the biosensors was calculated as blank frequency
response by PBS + 3 noise (standard deviation).30 The detec-
tion limit of E1 was calculated as 0.45 ng mL1 of CEA
concentration and that of E2 was better with a value of 0.33 ng
mL1. The upper saturation points of the biosensors were4124 | RSC Adv., 2020, 10, 4118–4128calculated from the log–log plots and for E1, the value obtained
was about 91 ng mL1 and that for E2 was about 113 ng mL1.
The LOD values are better than that of many reported studies
and a comparison with some of the piezoelectric biosensors for
CEA detection is given in the supportive data as Table S2.† The
performance of both the biosensor methods was also evaluated
through the calculation of total mass deposition on the elec-
trode crystal using experimental values and theoretical calcu-
lation using the concentration of CEA solutions. Since the
concentrations of solutions used for the immunoassay run are
known, the weight of total CEA in each sample was calculated
for the total ow of the sample and the obtained values were
compared with the experimental results achieved through
modied Sauerbrey's equation. The comparison is listed in
Table S1† as supportive data. According to the values obtained,
the accuracy of the biosensor was found to be good and the
results show less than 10% deviation from the theoretical
values. The sensitivity of the biosensors was calculated usingThis journal is © The Royal Society of Chemistry 2020
Fig. 9 (A) Immunoassay response of E2 (B) average value of variation in oscillation frequency from base value of E2 (C) calibration curves of E2.
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View Article OnlineSauerbrey's equation and impressive values of 87 and 123 Hz
ng1 of CEA were found, respectively, for E1 and E2. The
reproducibility study was conducted as per the studies reported
by M. Y. Emran et al.31–34 The results were found to be in good
agreement for both the bioreceptors. Both the bioreceptors did
not show much diﬀerence in performance till the 8th immu-
noassay run and in subsequent runs, the frequency shi started
deteriorating. The average values of variation in the immuno-
assay response as a function of reproducibility are given in
Fig. S1.†3.4. Sorption equilibrium of CEA on the bioreceptor sensing
interphase
Langmuir isotherm was used to understand the favourable
nature of adsorption of CEA on the bioreceptor. The experi-
mental data t well with the Langmuir adsorption isotherm, as
depicted in Fig. 10A and B for both E1 and E2, respectively. A
linear t for kobs versus C for both E1 and E2 suggests that theThis journal is © The Royal Society of Chemistry 2020sorption follows Langmuir adsorption isotherm. The isotherm
enables to calculate the kinetic constants of adsorption (ka) and
desorption (kd) as 2991  524 L mol1 s1 and (6.83  1.81) 
104 s1, respectively, as the slope and intercept of the graph for
E1. A non-zero value for kd implies an existing equilibrium
within the A-CEA–CEA interface. For E2, on the other hand, the
most signicant observation noted is the low kd ((8.95  1.75) 
105 s1) value and increased ka (3672  341 L mol1 s1), as
compared to the untreated immunoassay samples. This further
suggests increased activity of the bioreceptor interface through
oxygen plasma treatment and shied equilibrium of anti-CEA–
CEA interaction, which is more towards the forward reaction
side (association). In other words, the equilibrium attained with
reduced dissociation rate may be due to the stronger anti-CEA–
CEA interaction facilitated by the increased stability of bio-
receptor E2.
The observations from the isotherm study are in good
correlation with the frequency response study, as discussed in
the prior section, since there is considerably higher depressionRSC Adv., 2020, 10, 4118–4128 | 4125
Fig. 10 Representative Langmuir adsorption plot for the bioreceptors (A) E1 and (B) E2.
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View Article Onlinein frequency for oxygen plasma treated electrode crystal, E2,
than that of its untreated counterpart, E1. Better interaction
with the bioreceptor and ligand may tend to reduce the rate of
backward reaction. This can end as a higher equilibrium
deposited mass on E2 and the corresponding increase in the
frequency shi towards more negative side.
Also, the free energy of sorption process was calculated and
negative values for E1 and E2 were obtained. However,
DGsorption for E2 is observed as a more negative value than that
of E1, which also supports the concept of better ease for anti-
CEA–CEA association on the oxygen plasma treated bioreceptor
interface. DGsorption reported for E1 is 6.1  0.36 kcal mol1
and that for E2 is 6.6  0.52 kcal mol1. These values are
observed to be higher than that of the previous studies that
report similar experiments.29,30 The negative DGsorption values
suggest favourable sorption process of CEA on the newly
prepared SAM based bioreceptors surfaces. Additional evidence
for the same has been obtained by nding the type of Langmuir
sorption isotherm using the factor RL, a dimensionless constant
separation factor (L mmol1).
RL ¼ 1/(1 + bC0) (1)
According to the concept, if RL > 1, the sorption is unfav-
ourable, while 0 < RL < 1 suggests favourable conditions for
sorption, and RL ¼ 0 suggests irreversible reaction. The RL
values calculated for E1 are reported in the range of 0.74–0.93
and that of E2 are in the range of 0.65–0.85 L mmol1.3.5. Long-term stability and selectivity of the biosensor
The selectivity of the biosensor was tested using other non-
specic proteins such as alpha-1-fetoprotein (AFP), cancer
antigen 125 (CA125), and L-tryptophan. These proteins were
added in diﬀerent concentrations to 1 ng mL1 of CEA and the
frequency response was recorded (Fig. 11A and B). The perfor-
mance of both the biosensors E1 and E2 is free from the
interference of non-specic adsorption of other protein mole-
cules presented in the sample solutions. The frequency
response was recorded in a similar region as that for the 1 ng4126 | RSC Adv., 2020, 10, 4118–4128mL1 CEA stock solutions. However, the response time was
delayed by 15–20 minutes, as compared to the stock solution
analysis. The combinations of protein solutions are listed in the
supportive data, Table S3.† The long-term stability of the
biosensor was tested by repeated immunoassay runs with 1 ng
mL1 of CEA solution for 60 days. Aer a regular interval of 5
days, the biosensor was tested and the results are given as the
average values of variation in the frequency shi for E1 and E2
in the Fig. 11C and D, respectively.
The biosensor receptors were stored at sterile conditions at
4 C aer each immunoassay experiment. The regeneration of
SAM was conducted through a glycine buﬀer solution run aer
each immunoassay experiment. During the initial 25 days of the
immunoassay run, the variation in the frequency shi was
recorded to be negligible and for another 10 days, the variation
was not more than 2–3% for E1. However, the variation in
frequency response increased steadily from 35th day onwards
and at the 60th day, an average diﬀerence of 18% was recorded
for the bioreceptor E1. On the other hand, E2 recorded excep-
tionally high stability since till the 40th day the decrease in
performance was negligible and a maximum of 17% decrease in
eﬃciency was observed for E2 at the end of the analysis period.
The bioreceptor E2 has shown high resistivity towards the
initiation in performance decrease till the 40th day as compared
to the bioreceptor E1. This may be due to the additional stability
of the bioreceptor obtained through oxygen plasma treatment,
as proposed in the previous sections.3.6. Real-time detection of clinical serum samples
The real-time application of the newly developed biosensor was
examined using clinical serum samples. A total of 10 serum
samples were subjected to the immunoassay run using the
biosensor and were also tested through ELISA method. The
collected samples were mainly from patients who were in the
early stages of colorectal cancer development. Prior to the
measurement, 0.5 mL of the serum sample was added to 2 mL
of PBS solution with pH 7.4. Further, the immunoassay run and
the calculation of the deposited mass on the electrode surface
was conducted as per the above-discussed methods. The resultsThis journal is © The Royal Society of Chemistry 2020
Fig. 11 (A) Immunoassay response during the selectivity study of the biosensors with various combinations of tumour marking proteins (Table
S3†) for E1 (B) E2 (C) average values of the decrease in biosensing performance with time in terms of variation in frequency shift for E1 and (D) E2.
Table 1 Clinical serum sample analysis results for bioreceptors E1 and
E2 in comparison with the ELISA method
No.
Biosensor E1
(ng mL1)
Biosensor E2
(ng mL1)
ELISA
(ng mL1)
1 25.1  2.48 25.4  2.33 25.3  3.12
2 20.1  2.46 20.3  2.15 20.8  2.81
3 34.4  2.31 34.3  2.16 34.1  3.44
4 37.6  3.62 37.3  3.35 37.1  3.96
5 21.0  3.54 21.3  3.29 21.3  4.23
6 37.7  3.33 37.5  3.15 38.0  4.12
7 34.4  2.61 34.7  2.36 34.4  3.23
8 30.3  2.34 30.9  2.04 31.4  2.34
9 29.9  3.45 29.5  3.15 30.3  3.77
10 33.8  2.46 34.2  2.11 34.0  3.51
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View Article Onlineare depicted in Table 1 in comparison with the results obtained
through the ELISA method. The study found no signicant
diﬀerence in the results given by the two methods. Also, the
biosensor reported better consistency in the results, which is
proved by the smaller standard deviations values than those for
the ELISA results. Also, the response time is much faster for the
biosensor (40–50 minutes) than that of the ELISA method (6–8
hours).This journal is © The Royal Society of Chemistry 20204. Conclusions
QCM biosensor for the real-time detection of CEA was
successfully prepared through a SAM-based biosensor. The
study proposes a simple, sensitive, eﬃcient, and highly selective
piezoelectric immunosensing method for CEA detection and
estimation. The limit of detection of the biosensor was found to
be 0.06 and 0.09 ng mL1 of CEA concentration for the bio-
receptors prepared with and without oxygen plasma treatment,
respectively. The bioreceptors were prepared through GO-AuNP
coating on the QCM electrode by in situ synthesis method and
systematic integration of thioglycolic acid coupling unit
through EDC–NHS reaction mechanism. Oxygen plasma treat-
ment of the electrode surface in the initial stage of bioreceptor
preparation provided additional stability and sensitivity to the
biosensor. Also, theoretical analysis using Langmuir sorption
isotherm kinetics allowed to calculate ka, kd, and DG during the
immunoassay run and suggested a stable bioreceptor – prey
molecule interaction. The biosensor is suitable for multiple
immunoassay runs since the standard deviation of the test
results were found to be small and till the 45th day of biosensor
preparation, the decrease in the biosensing eﬃciency was found
to be less than 2%. The selectivity of the biosensor was also
observed to be satisfactory with other common tumor markingRSC Adv., 2020, 10, 4118–4128 | 4127
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View Article Onlineproteins such as AFP, CA125, and L-tryptophan. Clinical serum
sample analysis has suggested the biosensor to be promising
for the real-time detection of CEA. The test result was validated
using the ELISA method and found to be comparable but with
faster response time.
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